Skip to content
Search

Latest Stories

Self-Care Strategy Group calls for expansion of prescribing rights

Self-Care Strategy Group calls for expansion of prescribing rights

The Group urges Wes Streetingto maximise self-care benefitsto strengthen NHS and reduce pressure on GPs

The Self-Care Strategy Group (SCSG), comprising of leading pharmacy groups, professional organisations, trade associations and charities committed to self-care, has written to Wes Streeting MP, Secretary of State for Health and Social Care, urging the government to fully realise the benefits of self-care and work collaboratively to build an NHS fit for the future.

In its letter, the SCSG has outlined several key proposals including:


  • Expansion of prescribing rights.
  • Optimisation of digital health tools such as the NHS App.
  • Enabling direct referrals between primary, diagnostic and specialist care services
  • Widening access to self-care medicines in pharmacies.
  • Training Primary Care Network (PCN) staff to support patients in navigating the care system.
  • Promoting credible health information on self-care and expanding public awareness campaigns

Dr Graham Jackson, a GP and Chair of SCSG, expressed concerns over the unprecedented pressures on the NHS and primary care, cautioning that these challenges are likely to increase without urgent action.

He emphasised the importance of collaborating with the Health Secretary and the government to unleash the full benefits of selfcare and build an NHS fit for the future.

The letter reads: “As you will be aware, self-care for minor and self-treatable conditions is a vital tool in managing capacity within primary and emergency care settings.

“With the NHS requiring significant investment to reduce waiting lists, improve diagnostic capacity and tackle the workforce crisis, cost-efficient means of relieving capacity in GP practices and A&E departments, as well as across primary care, are clearly needed.

“Self-care offers one solution to this problem, enabling systemic change to the UK’s approach to healthcare, including in deprived and rural communities.”

In 2021, the Self-Care Strategy Group released a comprehensive blueprint for a national self-care strategy, which included nine recommendations aimed at enhancing support and promotion of self-care in England.

The recommendations range from improving health literacy in the school curriculum and modernising digital health infrastructure to empowering pharmacists and widening patient access to self-care medicines through reclassification.

The Group has welcomed the NHS's progress in implementing self-care policies that improved access to pharmacy and primary care navigation. However, they noted that there is still significant potential to fully capitalize on the benefits of self-care.

“In line with your manifesto commitments, we believe opportunities exist to expand prescribing rights, optimise digital health tools (such as the NHS App), and enable direct referrals between primary, diagnostic and specialist care services – but also that there is potential to go further.

“By widening access to self-care medicines in pharmacies, training Primary Care Network (PCN) staff to support patients in navigating the care system, promoting credible health information and expanding public awareness campaigns, the benefits of self-care could be fully realised,” they wrote.

The group sought the opportunity to meet with Streeting to discuss how self-care can assist the government in alleviating pressure on GPs and A&E departments and serve as the foundation for a future-ready NHS.

More For You

13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less
 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less
MHRA approves Pfizer Hympavzi (marstacimab) for haemophilia treatment

Marstacimab is currently being assessed by NICE and the Scottish Medicines Consortium for use on the NHS

gettyimages

Marstacimab approved for haemophilia treatment, Pfizer aims for NHS availability

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hympavzi(marstacimab) to prevent or reduce bleeding in patients aged 12 years and older, weighing at least 35kg, who have severe haemophilia A or B.

Developed by Pfizer scientists, this groundbreaking treatment is the first of its kind to target a protein involved in the blood clotting process.

Keep ReadingShow less